Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3,706 | 1,933 | 179 | 39 | 113 |
| Income taxes - deferred | -790 | -307 | N/A | N/A | N/A |
| Accounts receivable | -7,258 | 1,159 | -77 | -254 | 1 |
| Accounts payable and accrued liabilities | N/A | -501 | N/A | N/A | N/A |
| Other Working Capital | -1,491 | 1,568 | -713 | -168 | -295 |
| Other Operating Activity | 4,211 | -5,792 | -2,379 | -561 | -810 |
| Operating Cash Flow | $-1,622 | $-1,940 | $-2,990 | $-944 | $-991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -73 | -33 | -7 | -3 | -3 |
| Net Acquisitions | -27,935 | -16,886 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -769 | -397 | -557 | -329 | -505 |
| Other Investing Activity | 206 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-28,571 | $-17,315 | $-563 | $-332 | $-508 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 18,897 | 31,456 | N/A | N/A | 0 |
| Debt Repayment | -314 | -5,190 | N/A | 0 | -3 |
| Common Stock Issued | 0 | 14,986 | 3,872 | 0 | 71 |
| Common Stock Repurchased | -2,636 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,346 | -2,876 | -33 | 0 | 0 |
| Financing Cash Flow | $14,602 | $38,376 | $3,838 | $0 | $68 |
| Exchange Rate Effect | 233 | 50 | N/A | N/A | N/A |
| Beginning Cash Position | 20,593 | 2,703 | 2,510 | 3,705 | 5,238 |
| End Cash Position | 5,235 | 21,873 | 2,794 | 2,430 | 3,807 |
| Net Cash Flow | $-15,592 | $19,121 | $285 | $-1,275 | $-1,431 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,622 | -1,940 | -2,990 | -944 | -991 |
| Capital Expenditure | -842 | -429 | -563 | -332 | -508 |
| Free Cash Flow | -2,464 | -2,369 | -3,554 | -1,275 | -1,499 |